Synthesis and characterization of palladium(II) and platinum(II) complexes with Schiff bases derivatives of 2-pyridincarboxyaldehyde. Study of their interaction with DNA

Journal of Inorganic Biochemistry

Volumn 100, Issue 8, 2006, Pages 1368-1377

  García Friaza, Gloria ^a   Fernández Botello, Alfonso ^a   Pérez, Jose M ^b   Prieto, Maria J ^a   Moreno, Virtudes ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

AFM imaging; Palladium complexes; Platinum antitumor complexes; Schiff bases

Indexed keywords

2 PYRIDINCARBOXYALDEHYDE; ANTINEOPLASTIC AGENT; CISPLATIN; PALLADIUM COMPLEX; PLASMID DNA; PLATINUM COMPLEX; SCHIFF BASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ATOMIC FORCE MICROSCOPY; CANCER RESISTANCE; CIRCULAR DICHROISM; CONTROLLED STUDY; COVALENT BOND; DNA ADDUCT; DRUG DETERMINATION; DRUG DNA BINDING; DRUG SENSITIVITY; DRUG SYNTHESIS; FOURIER ANALYSIS; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR INTERACTION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OVARY TUMOR; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR CELL DESTRUCTION;

ALDEHYDES; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CISPLATIN; DNA; DNA ADDUCTS; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; MASS SPECTROMETRY; MICROSCOPY, ATOMIC FORCE; MOLECULAR STRUCTURE; ORGANIC CHEMICALS; OVARIAN NEOPLASMS; PALLADIUM; PLATINUM; PYRIDINES; SCHIFF BASES;

EID: 33745604903     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2006.03.011     Document Type: Article

References (34)

1. Rosenberg B., vanCamp L., Trosko J.E., and Mansour V.H. Nature 222 (1969) 385-386
2. Lippard S.J. Progress in Inorganic Chemistry. Bioinorganic Chemistry vol. 48 (1995), Wiley, Sydney
3. Lippert B. Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug (1999), Wiley-VCH, Weinheim
4. Fuertes M.A., Castilla J., Alonso C., and Pérez J.M. Curr. Med. Chem. 10 (2003) 257-266
5. Schrier R.W. J. Clin. Invest. 110 (2002) 743-745
6. Reedijk J. Curr. Opin. Chem. Biol. 3 (1999) 236-240
7. Wimmer F.L., Wimmer S., Castan P., Cros S., Johnson N., and Colacio-Rodríguez E. Anticancer Res. 9 (1989) 791-793
8. Flaherty K.T., Stevenson J.P., Redlinger M., Algazy K.M., Giantonio B., and O'Dwyer P.J. Cancer Chemother. Pharmacol. 53 (2004) 404-408
9. Coluccia M., Nassi A., Boccarelli A., Giordano D., Cardellicchio N., Intini F.P., Natile G., Barletta A., and Paradiso A. Int. J. Oncol. 15 (1999) 1039-1044
10. Qu Y., Rauter H., Fontes A.P.S., Bandarage R., Kelland Ll.R., and Farrell N. J. Med. Chem. 43 (2000) 3189-3192
11. Gandolfi O., Apfelbaum H.C., and Blum J. Inorg. Chim. Acta 135 (1987) 27-31
12. Vicini P., Geronikaki A., Incerti M., Busomera B., Poni G., Cabras C.A., and La Colla P. Bioorg. Med. Chem. 11 (2003) 4785-4789
13. Offiong O.E., Nfor E., Ayi A.A., and Martelli S. Transition Met. Chem. 25 (2000) 369-373
14. Ali M.A., Mirza A.H., Butcher R.J., Tarafder M.T.H., Keat T.B., and Ali A.M. J. Inorg. Biochem. 92 (2002) 141-148
15. Chakraborty J., and Patel R.N. J. Ind. Chem. Soc. 73 (1996) 191-193
16. Price J.H., Williamson A.N., Schramm R.F., and Wayland B.B. Inorg. Chem. 11 (1972) 1280-1284
17. Navarro-Ranninger C., Pérez J.M., Zamora F., González V.M., Masaguez J.R., and Alonso C. J. Inorg. Biochem. 52 (1993) 37-49
18. Navarro-Ranninger C., López-Solera I., Pérez J.M., Rodríguez J., García-Ruano J.L., Raithby P.R., Masaguez J.R., and Alonso C. J. Med. Chem. 36 (1993) 3795-3801
19. Maniatis, Molecular Cloning, a Laboratory Manual. Cold Spring Harbor Laboratory Press, 1989.
20. Alley M.C., Scudeiro D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., Abbott B.J., Mayo J.G., Shoemaker R.H., and Boyd M.R. Cancer Res. 48 (1988) 589-601
21. Vermes I., Haanen C., Steffens-Nakken H., and Reutelingsperger C. J. Immunol. Methods 184 (1995) 39-51
22. Pregosin P.S. Coord. Chem. Rev. 44 (1982) 247-291
23. Pregosin P.S. Transition Metal Nuclear Magnetic Resonance (1991), Elsevier, Zürich, Switzerland
24. Zaludová R., Zakovska A., Kaspárková J., Balcarová Z., Kleinwächter V., Vrana O., Farrell N., and Brabec V. Eur. J. Biochem. 246 (1997) 508-517
25. Brabec V., Kleinwächter V., Butour J.L., and Johnson N.P. Biophys. Chem. 35 (1990) 129-141
26. González V.M., Amo-Ochoa P., Pérez J.M., Fuertes M.A., Masaguer J.R., and Navarro-Ranninger C. J. Inorg. Biochem. 63 (1996) 57-68
27. Johnson A., Qu Y., Van Hounten B., and Farrell N. Nucleic Acid Res. 20 (1992) 1697-1703
28. Johnson W.C., Itzkowitz M.S., and Tinoco I. Biopolymers 11 (1972) 225-234
29. Riera X., Caubet A., López C., and Moreno V. Polyhedron 18 (1999) 2549-2555
30. Ushay H.M., Tullius T.D., and Lippard S.J. Biochemistry 20 (1981) 3744-3748
31. Keck M.V., and Lippard S.J. J. Am. Chem. Soc. 114 (1992) 3386-3390
32. Anselmetti D., Fritz J., Smith B., and Fernández-Busquets X. Single Mol. 1 (2000) 53-58
33. Molenaar C., Teuben J.-M., Heetebrij R.J., Tanke H.J., and Reedijk J. J. Biol. Inorg. Chem. 5 (2000) 655-665
34. Fuertes M.A., Alonso C., and Perez J.M. Chem. Rev. 103 (2003) 645-662